3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
28
Recruiting
23
Unknown
9
Active not recruiting
6
Terminated
3
Not yet recruiting
3
Suspended
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
10
CNS
8
Thoracic
7
Head & Neck
6
Breast
5
Other hematologic neoplasm
4
Lymphoid
3
Gynecologic
3
Genitourinary
3
Other solid neoplasm
2
Sarcoma
1
Other neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Breast Neoplasms
1
Interventions
Paclitaxel
24
Carboplatin
18
Bevacizumab
14
Cisplatin
10
pembrolizumab
7
fluzoparib
7
Radiotherapy
6
Drug Therapy
6
apatinib
5
Topotecan
5
Magnetic Resonance Spectroscopy
5
Injections
5
liposomal doxorubicin
4
lenvatinib
4
famitinib
4
camrelizumab
4
Tirzepatide
4
Specimen Handling
4
Platinum
4
Observation
4
Gemcitabine
4
Brachytherapy
4
toripalimab
3
olaparib
3
dostarlimab
3
anlotinib
3
Watchful Waiting
3
Therapeutics
3
Surveys and Questionnaires
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT07555600
2026-04-29
E-FACTOR
Centre Leon Berard
Phase NA
Not yet recruiting
300 enrolled
NCT07093593
2025-07-30
RAMA
Centre Georges Francois Leclerc
Phase NA
Not yet recruiting
260 enrolled
NCT06677242
2025-02-10
SEIC
Erasmus Medical Center
Not yet recruiting
100 enrolled